FDA on Key Stem Cell Regulatory Issues & Its Own Research
It’s been a seemingly rather quiet year on the FDA regulatory front in the US when it comes to direct-to-consumer stem cell interventions even as the number of dubious stem cell clinics continues to skyrocket. I requested an interview with the FDA to cover the key pressing issues in this arena. I want to thank […]
FDA on Key Stem Cell Regulatory Issues & Its Own Research Read More »